PKD patients who receive kidney transplants may have a reduced risk of cancer
5/25/2014

Patients with a certain form of kidney disease may have a reduced risk of cancer compared with patients with other kidney diseases, according to a study appearing in an upcoming issue of the Journal...

Understanding of how Taxol works could lead to better anticancer drugs
5/25/2014

University of California, Berkeley, scientists have discovered the extremely subtle effect that the prescription drug Taxol has inside cells that makes it one of the most widely used anticancer...

Image fusion-guided biopsy improves accuracy of prostate cancer diagnosis
5/24/2014

A recent study by investigators from LIJ Medical Center demonstrated that using magnetic resonance imaging (MRI) in men with an elevated prostate specific antigen (PSA) resulted in a prostate cancer...

For dysplastic Barrett's esophagus, radiofreqeuncy ablation and complete endoscopic resection equally effective
5/24/2014

According to a new systematic review article, radiofrequency ablation and complete endoscopic resection are equally effective in the short-term treatment of dysplastic Barrett's esophagus, but...

FDA approves first molecular (gene-based) test to determine red blood cell types in transfusion medicine
5/23/2014

The U.S. Food and Drug Administration has approved the Immucor PreciseType Human Erythrocyte Antigen (HEA) Molecular BeadChip Test - the first FDA-approved molecular assay used in transfusion...

New anticancer compound discovered using accelerated drug screening process
5/23/2014

A team of research scientists from VTT Technical Research Centre of Finland, the University of Turku and the University of Eastern Finland has discovered a previously unknown Cent-1 molecule that...

New test to diagnose cancer- and infertility-causing parasite
5/23/2014

Schistosomiasis is endemic in the world's poorest countries. New research sheds more light on how the parasite behind this disease operates, resulting in a new screening technique.

Worse side effects from chemotherapy experienced when biological rhythms interrupted
5/23/2014

Patients receiving chemical treatment for cancer often suffer fatigue and body weight loss, two of the most worrying effects of this therapy linked to the alteration of their circadian rhythms.

Tumor modeling predicts most effective drugs targeting brain cancer
5/23/2014

Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have used computer simulations of cancer cells - cancer avatars - to identify drugs most likely to kill...

Height hormone offers target for fighting cancer and diabetes
5/22/2014

After discovering which part of the growth hormone molecule switches on its receptor, researchers say it offers a target for drugs to fight cancer and diabetes.